Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BATF | hg38_v1_chr14_+_75522531_75522560 | 0.27 | 1.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_89010515 Show fit | 5.37 |
ENST00000493819.1
|
immunoglobulin kappa variable 1-9 |
|
chr22_+_22711689 Show fit | 5.05 |
ENST00000390308.2
|
immunoglobulin lambda variable 3-21 |
|
chr2_+_88885397 Show fit | 4.83 |
ENST00000390243.2
|
immunoglobulin kappa variable 4-1 |
|
chr14_-_106622837 Show fit | 4.16 |
ENST00000390628.3
|
immunoglobulin heavy variable 1-58 |
|
chr3_+_151814102 Show fit | 4.14 |
ENST00000232892.12
|
arylacetamide deacetylase |
|
chr2_+_89947508 Show fit | 4.13 |
ENST00000491977.1
|
immunoglobulin kappa variable 2D-29 |
|
chr2_-_89320146 Show fit | 4.03 |
ENST00000498574.1
|
immunoglobulin kappa variable 1-39 |
|
chr17_-_40565459 Show fit | 3.95 |
ENST00000578085.1
ENST00000246657.2 |
C-C motif chemokine receptor 7 |
|
chr4_+_40191037 Show fit | 3.94 |
ENST00000505618.5
|
ras homolog family member H |
|
chr14_-_94388589 Show fit | 3.85 |
ENST00000402629.1
ENST00000556091.1 ENST00000393087.9 ENST00000554720.1 |
serpin family A member 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 94.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 48.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 14.8 | GO:0045576 | mast cell activation(GO:0045576) |
1.0 | 13.6 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 11.9 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.0 | 7.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 7.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.7 | 6.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.5 | 6.8 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 6.7 | GO:0002250 | adaptive immune response(GO:0002250) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 37.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 35.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 33.9 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 22.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 21.9 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.6 | 15.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 10.5 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 9.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 8.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 7.6 | GO:0034774 | secretory granule lumen(GO:0034774) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 138.7 | GO:0003823 | antigen binding(GO:0003823) |
0.4 | 15.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 12.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 10.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 9.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 8.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 7.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 7.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 6.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.9 | 5.8 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 26.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 15.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 13.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 10.5 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 9.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 8.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 8.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 7.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 6.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 6.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 18.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 15.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 14.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 12.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 8.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 7.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 7.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 6.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 6.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 6.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |